BioPorto A/S (THOXF)
THOXF Stock Price Chart
Explore BioPorto A/S interactive price chart. Choose custom timeframes to analyze THOXF price movements and trends.
THOXF Company Profile
Discover essential business fundamentals and corporate details for BioPorto A/S (THOXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
13 Dec 2019
Employees
48.00
Website
https://bioporto.comCEO
Peter Moerch Eriksen BBA
Description
BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. It sells its products through own sales team, distributors, and OEM partnerships. The company was founded in 2000 and is headquartered in Hellerup, Denmark.
THOXF Financial Timeline
Browse a chronological timeline of BioPorto A/S corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 18 Mar 2026
Upcoming earnings on 19 Nov 2025
Earnings released on 15 Aug 2025
EPS came in at -$0.01 surpassing the estimated -$0.01 by +19.29%, while revenue for the quarter reached $1.67M , missing expectations by -88.48%.
Earnings released on 8 May 2025
EPS came in at -$0.06 falling short of the estimated -$0.01 by -782.73%, while revenue for the quarter reached $7.67M , missing expectations by -33.33%.
Earnings released on 20 Mar 2025
EPS came in at -$0.01 surpassing the estimated -$0.01 by +24.34%, while revenue for the quarter reached $1.09M , missing expectations by -28.21%.
Earnings released on 14 Nov 2024
EPS came in at -$0.01 surpassing the estimated -$0.01 by +4.16%, while revenue for the quarter reached $1.43M , missing expectations by -87.04%.
Earnings released on 15 Aug 2024
EPS came in at -$0.01 falling short of the estimated -$0.00 by -38.37%, while revenue for the quarter reached $1.32M , beating expectations by +10.05%.
Earnings released on 8 May 2024
EPS came in at -$0.01 falling short of the estimated -$0.00 by -15.54%, while revenue for the quarter reached $1.36M , beating expectations by +36.99%.
Earnings released on 22 Feb 2024
EPS came in at -$0.00 , while revenue for the quarter reached $968.05K .
Earnings released on 30 Sept 2023
EPS came in at -$0.00 surpassing the estimated -$0.01 by +36.93%, while revenue for the quarter reached $1.21M , beating expectations by +8.74%.
Stock split effective on 10 Aug 2023
Shares were split 1039 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -15.73%, while revenue for the quarter reached $1.13M , missing expectations by -1.93%.
Earnings released on 31 Mar 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -0.29%, while revenue for the quarter reached $1.17M , beating expectations by +3.51%.
Earnings released on 30 Mar 2023
EPS came in at -$0.08 falling short of the estimated -$0.07 by -14.29%, while revenue for the quarter reached $1.26M , beating expectations by +71.50%.
Earnings released on 9 Nov 2022
EPS came in at -$0.05 surpassing the estimated -$0.06 by +16.67%, while revenue for the quarter reached $690.82K , missing expectations by -12.38%.
Earnings released on 17 Aug 2022
EPS came in at -$0.05 matching the estimated -$0.05, while revenue for the quarter reached $1.19M , beating expectations by +33.87%.
Earnings released on 11 May 2022
EPS came in at -$0.06 surpassing the estimated -$0.07 by +14.29%, while revenue for the quarter reached $967.00K , beating expectations by +1.57%.
Earnings released on 6 Apr 2022
EPS came in at -$0.01 surpassing the estimated -$0.06 by +84.12%, while revenue for the quarter reached $1.04M , beating expectations by +4.43%.
Earnings released on 17 Nov 2021
EPS came in at -$0.04 surpassing the estimated -$0.07 by +42.86%, while revenue for the quarter reached $825.97K .
Earnings released on 18 Aug 2021
EPS came in at -$0.05 surpassing the estimated -$0.06 by +16.67%, while revenue for the quarter reached $1.05M .
Earnings released on 12 May 2021
EPS came in at -$0.06 surpassing the estimated -$0.07 by +14.29%, while revenue for the quarter reached $881.09K .
Earnings released on 17 Mar 2021
EPS came in at -$0.06 matching the estimated -$0.06, while revenue for the quarter reached $1.24M .
Stock split effective on 1 Feb 2021
Shares were split 119 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 18 Nov 2020
EPS came in at -$0.09 falling short of the estimated -$0.05 by -80.00%, while revenue for the quarter reached $747.32K .
THOXF Stock Performance
Access detailed THOXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.